Advice
in the absence of a submission from the holder of the marketing authorisation:
hydrocortisone (Efmody®) is not recommended for use within NHSScotland.
Indication under review: in adolescents aged 12 years and over and adults for the treatment of adrenal insufficiency (AI).
The holder of the marketing authorisation has not made a submission to SMC regarding this product in this indication. As a result, we cannot recommend its use within NHSScotland.
Download detailed advice366KB (PDF)
Medicine details
- Medicine name:
- hydrocortisone (Efmody)
- SMC ID:
- SMC2971
- Indication:
In adolescents aged 12 years and over and adults for the treatment of adrenal insufficiency (AI)
- Pharmaceutical company
- Immedica
- BNF chapter
- Endocrine system
- Submission type
- Non submission
- Status
- Not recommended
- Date advice published
- 07 September 2026